H. Hirano

Fluorine-18 (18F)-labeled retinoid x receptor (RXR) partial agonist whose tissue transferability is affected by other RXR ligands.

Takanori Sasaki, Michiko Fujihara, H. Kakuta, 2019, Bioorganic & medicinal chemistry.

Synthesis of 11C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof.

Takanori Sasaki, Akiya Akahoshi, T. Hanada, 2017, Journal of medicinal chemistry.

Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene.

Takanori Sasaki, Hiroyuki Hirano, H. Kakuta, 2022, ACS pharmacology & translational science.

In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging.

Takanori Sasaki, Kazuko Kobayashi, Shoichi Kita, 2017, Autoimmunity reviews.

Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.

Takanori Sasaki, Fumiaki Takenaka, E. Matsuura, 2015, ACS medicinal chemistry letters.